Skip to content

Zymeworks ZYME Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin-140.4%-53.0pp-87.3%-34.8pp-52.5%+14.8pp-67.3%+66.5pp-133.8%+45.9pp
Net margin-126.3%-49.8pp-76.6%-29.4pp-47.2%+12.8pp-60%+61.8pp-121.7%+39.1pp
Returns
Return on equity-42%-15.3pp-26.7%-8.3pp-18.5%+1.4pp-19.9%+9.9pp-29.8%+0.7pp
Efficiency
Asset turnover0.2×-0.1×0.3×0.0×0.3×0.0×0.3×+0.1×0.2×0.0×
Liquidity
Current ratio10.8×+4.9×5.9×-1.1×6.9×-0.8×7.7×+3.0×4.7×+1.3×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Per Share
Book value per share$2.19-38.5%$3.56-15.7%$4.22-2.3%$4.32+0.1%$4.32-3.2%
Valuation
Market capitalization$1.86B-6.3%$1.99B+53.5%$1.29B+34.8%$959.51M+15.8%$828.66M-17.8%
Price / sales22.9×+4.2×18.7×+9.1×9.6×+1.8×7.8×-1.1×8.9×-4.3×
Price / book11.4×+4.0×7.4×+3.4×+1.2×2.9×+0.3×2.6×-0.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Zymeworks's ratios come from?
Every ratio is computed from Zymeworks's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.